Huachen Future Information

Huachen future (Beijing) Biomedical Technology Co., Ltd. focuses on the R & D and production of stem cell drugs. In the Daxing District of Beijing, we have a 1000 square meters cGMP facility equipped with cell therapy isolators, and 2D, 3D mesenchymal stem cell production systems. At present, several animal models of human diseases have been successfully established, and the effectiveness of stem cell therapy has been verified. 华辰未来成立于2018年9月，注册资本2000万，专注于干细胞药物的研发和生产。现为中关村高新技术企业。在北京大兴区拥有1000平米cGMP生产车间，配有隔离器细胞生产设备，以及2D、3D间充质干细胞的生产体系。目前已成功建立多个人类疾病动物模型，并开展了干细胞治疗的有效性验证。